Literature DB >> 21289151

Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.

Elizabeth M Marlowe1, Susan M Novak-Weekley, Joven Cumpio, Susan E Sharp, Michelle A Momeny, Anna Babst, Jonathan S Carlson, Masae Kawamura, Mark Pandori.   

Abstract

A total of 217 specimens submitted for routine smear and culture from three different sites within the western United States were used to evaluate the GeneXpert MTB/RIF assay (for research use only) (Cepheid, Sunnyvale, CA). Overall agreement compared to culture was 89% (98% for smear positives and 72% for smear negatives) for detection of Mycobacterium tuberculosis.

Entities:  

Mesh：

Year:  2011        PMID： 21289151      PMCID： PMC3122817          DOI： 10.1128/JCM.02214-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

Review 1.  Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  Evaluation of the analytical performance of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Elizabeth Story; Danica Helb; JoAnn Kop; Padmapriya Banada; Michelle R Owens; Soumitesh Chakravorty; Martin Jones; David Alland
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

3.  Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis.

Authors:  S Morris; G H Bai; P Suffys; L Portillo-Gomez; M Fairchok; D Rouse
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

4.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

5.  Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-01-16       Impact factor: 17.586

6.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

Review 7.  Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.

Authors:  A Rattan; A Kalia; N Ahmad
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883
  7 in total
  100 in total

1.  Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa.

Authors:  L E Scott; N Gous; B E Cunningham; B D Kana; O Perovic; L Erasmus; G J Coetzee; H Koornhof; W Stevens
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

2.  Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens.

Authors:  Arzu N Zeka; Sezai Tasbakan; Cengiz Cavusoglu
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

Review 3.  Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance.

Authors:  Stephen D Lawn; Mark P Nicol
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

4.  A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Pamela Nabeta; Amy L Davidow; Viral Vadwai; Rasim Tahirli; Vanisha Munsamy; Mark Nicol; Martin Jones; David H Persing; Doris Hillemann; Sabine Ruesch-Gerdes; Felicity Leisegang; Carlos Zamudio; Camilla Rodrigues; Catharina C Boehme; Mark D Perkins; David Alland
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

5.  Performance of Xpert MTB/RIF Assay in Diagnosis of Pleural Tuberculosis by Use of Pleural Fluid Samples.

Authors:  Syed Beenish Rufai; Amit Singh; Parveen Kumar; Jitendra Singh; Sarman Singh
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

6.  Quantitative detection of cells expressing BlaC using droplet-based microfluidics for use in the diagnosis of tuberculosis.

Authors:  Fengjiao Lyu; Manqi Xu; Yunfeng Cheng; Jinghang Xie; Jianghong Rao; Sindy K Y Tang
Journal:  Biomicrofluidics       Date:  2015-08-20       Impact factor: 2.800

7.  Comparative Study of GeneXpert with ZN Stain and Culture in Samples of Suspected Pulmonary Tuberculosis.

Authors:  Monika Agrawal; Ashish Bajaj; Vinay Bhatia; Sarjana Dutt
Journal:  J Clin Diagn Res       Date:  2016-05-01

8.  A patient with severe peritonitis.

Authors:  J C Samuel; E K Ludzu; B A Cairns; C Varela; A G Charles
Journal:  Malawi Med J       Date:  2013-09       Impact factor: 0.875

9.  Performance of a Highly Sensitive Mycobacterium tuberculosis Complex Real-Time PCR Assay for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting: a Prospective Intervention Study.

Authors:  Víctor Vinuesa; Rafael Borrás; María Luisa Briones; María Ángeles Clari; Vicenta Cresencio; Estela Giménez; Carmen Muñoz; Rosa Oltra; Emilio Servera; Talia Scheelje; Carlos Tornero; David Navarro
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

Review 10.  Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test.

Authors:  Stephen D Lawn; Peter Mwaba; Matthew Bates; Amy Piatek; Heather Alexander; Ben J Marais; Luis E Cuevas; Timothy D McHugh; Lynn Zijenah; Nathan Kapata; Ibrahim Abubakar; Ruth McNerney; Michael Hoelscher; Ziad A Memish; Giovanni Battista Migliori; Peter Kim; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.